Resolution of left atrial appendage thrombus with apixaban

Thrombosis Journal

Volumn 11, Issue 1, 2013, Pages

  Kawakami, Tohru ^a   Kobayakawa, Hiroko ^a   Ohno, Hiroyoshi ^a   Tanaka, Nobukiyo ^a   Ishihara, Hiroki ^a  

^a Ichinomiyanishi Hospital   (Japan)

Author keywords

Apixaban; Atrial fibrillation; Left atrial appendage thrombus

Indexed keywords

APIXABAN; D DIMER; FIBRIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; CATHETER ABLATION; DYSPNEA; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART LEFT VENTRICLE FUNCTION; HEART PALPITATION; HOSPITAL ADMISSION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; NONISCHEMIC CARDIOMYOPATHY; PARTIAL THROMBOPLASTIN TIME; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 84890452234     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-11-26     Document Type: Article

References (17)

1. The European Atrial Fibrillation Trial Study Group Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 1995, 333:5-10. The European Atrial Fibrillation Trial Study Group.
2. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011, 365:981-992. 10.1056/NEJMoa1107039, 21870978.
3. Vidal A, Vanerio G. Dabigatran and left atrial appendage thrombus. J Thromb Thrombolysis 2012, 34:545-547. 10.1007/s11239-012-0747-1, 22644719.
4. Hammerstingl C, Potzsch B, Nickenig G. Resolution of giant left atrial appendage thrombus with rivaroxaban. Thromb Haemost 2013, 109:583-584. 10.1160/TH12-11-0821, 23348106.
5. Kimura M, Wasaki Y, Ogawa H, Nakatsuka M, Wakeyama T, Iwami T, Ono K, Nakao F, Matsuzaki M. Effect of low-intensity warfarin therapy on left atrial thrombus resolution in patients with nonvalvular atrial fibrillation: a transesophageal echocardiographic study. Jpn Circ J 2001, 65:271-274. 10.1253/jcj.65.271, 11316121.
6. Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Wann LS, Curtis AB, Ellenbogen KA, Estes NA, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Fuster V, Ryden LE, Cannom DS, Crijns HJ, et al. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol 2006, 2013(61):1935-1944.
7. Nair CK, Holmberg MJ, Aronow WS, Shen X, Li H, Lakkireddy D. Thromboembolism in patients with atrial fibrillation with and without left atrial thrombus documented by transesophageal echocardiography. Am J Ther 2009, 16:385-392. 10.1097/MJT.0b013e3181727b42, 19955857.
8. Habara S, Dote K, Kato M, Sasaki S, Goto K, Takemoto H, Hasegawa D, Matsuda O. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. Eur Heart J 2007, 28:2217-2222. 10.1093/eurheartj/ehm356, 17716991.
9. Mitusch R, Siemens HJ, Garbe M, Wagner T, Sheikhzadeh A, Diederich KW. Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy. Thromb Haemost 1996, 75:219-223.
10. Ota S, Wada H, Nobori T, Kobayashi T, Nishio M, Nishioka Y, Noda M, Sakaguchi A, Abe Y, Nishioka J, Ishikura K, Yamada N, Nakano T. Diagnosis of deep vein thrombosis by plasma-soluble fibrin or D-dimer. Am J Hematol 2005, 79:274-280. 10.1002/ajh.20396, 16044439.
11. Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, Pengo V, Ghirarduzzi A, Pattacini C, Testa S, Lensing AW, Tripodi A. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 2006, 355:1780-1789. 10.1056/NEJMoa054444, 17065639.
12. Ruiz-Gimenez N, Friera A, Artieda P, Caballero P, Sanchez Molini P, Morales M, Suarez C. Rapid D-dimer test combined a clinical model for deep vein thrombosis. Validation with ultrasonography and clinical follow-up in 383 patients. Thromb Haemost 2004, 91:1237-1246.
13. Wada H, Kobayashi T, Abe Y, Hatada T, Yamada N, Sudo A, Uchida A, Nobori T. Elevated levels of soluble fibrin or D-dimer indicate high risk of thrombosis. J Thromb Haemost 2006, 4:1253-1258. 10.1111/j.1538-7836.2006.01942.x, 16706968.
14. Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, Kovacs G, Mitchell M, Lewandowski B, Kovacs MJ. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003, 349:1227-1235. 10.1056/NEJMoa023153, 14507948.
15. Klein AL, Grimm RA, Murray RD, Apperson-Hansen C, Asinger RW, Black IW, Davidoff R, Erbel R, Halperin JL, Orsinelli DA, Porter TR, Stoddard MF. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001, 344:1411-1420. 10.1056/NEJM200105103441901, 11346805.
16. Klein AL, Murray RD, Grimm RA. Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation. J Am Coll Cardiol 2001, 37:691-704. 10.1016/S0735-1097(00)01178-5, 11693739.
17. Hori M, Matsumoto M, Tanahashi N, Momomura S, Uchiyama S, Goto S, Izumi T, Koretsune Y, Kajikawa M, Kato M, Ueda H, Iwamoto K, Tajiri M. Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation - the J-ROCKET AF study. Circ J 2012, 76:2104-2111. 10.1253/circj.CJ-12-0454, 22664783.